Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Taxus Cardium Pharmaceuticals Group Inc. (CRXM)
OTHER OTC:CRXM
Taxus Cardium Pharmaceuticals Group (CRXM) Financial Statements
31 Followers
Taxus Cardium Pharmaceuticals Group Financial Overview
| Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -476.66K | $ -388.70K | $ 424.09K | $ -152.88K | $ 1.45M |
| EBITDA | $ -476.00K | $ -388.33K | $ 424.46K | $ -152.46K | $ 1.46M |
| Net Income Common Stockholders | $ -442.79K | $ -361.13K | $ 435.79K | $ -149.76K | $ 1.45M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 386.03K | $ 781.57K | $ 1.31M | $ 2.93K | $ 400.00 |
| Total Assets | $ 566.98K | $ 974.82K | $ 1.34M | $ 129.67K | $ 35.44K |
| Total Debt | $ 1.26M | $ 1.34M | $ 1.22M | $ 1.22M | $ 1.12M |
| Net Debt | $ 874.44K | $ 554.59K | $ -96.78K | $ 1.21M | $ 1.12M |
| Total Liabilities | $ 5.14M | $ 5.05M | $ 5.02M | $ 5.15M | $ 4.89M |
| Stockholders Equity | $ -3.88M | $ -3.43M | $ -3.07M | $ -4.44M | $ -4.29M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -337.87K | $ -483.23K | $ -221.48K | $ -93.86K | $ -23.39K |
| Operating Cash Flow | $ -337.87K | $ -479.80K | $ -221.48K | $ -93.86K | $ -23.39K |
| Investing Cash Flow | $ -4.00 | - | - | - | - |
| Financing Cash Flow | $ -57.67K | $ -47.67K | $ 1.53M | $ 96.38K | $ -13.47K |
Taxus Cardium Pharmaceuticals Group Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.